Get 20% lifetime commission for referring investors to digrin.com
here.
Editas Medicine, Inc. ( EDIT) - Key Metrics
EDIT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.10 | -$0.15 | -$0.25 | -$0.25 |
| 2026Q1 | $0.03 | -$0.26 | -$0.24 | -$0.24 |
| 2025Q4 | $0.28 | -$0.06 | -$0.41 | -$0.41 |
| 2025Q3 | $0.08 | -$0.28 | -$0.34 | -$0.35 |
| 2025Q2 | $0.04 | -$0.63 | -$0.59 | -$0.59 |
EDIT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.40 |
| 2026Q1 | 0% | -2.38 |
| 2025Q4 | 0% | -8.87 |
| 2025Q3 | 0% | -3.10 |
| 2025Q2 | 0% | -0.87 |
EDIT
Price: $2.84
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.6 million
Ebitda: -26.1 millionMarket Capitalization: 453.1 million